Steve Wigginton, CEO, Valence Health at Evolent Health, Inc. (EVH), sold 988 shares at $20.20 ($20K) on 2017-03-03, disclosed to the SEC on 2017-03-07.
Scheduled sale ($20k) by CEO, Valence Health under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EVH | SELL | 2017-06-08 | $25K | — | Filing → |
| EVH | SELL | 2017-06-05 | $145K | — | Filing → |
| EVH | SELL | 2017-05-23 | $331K | — | Filing → |